NOTCH2 and non-small cell lung carcinoma: In NSCLC cells, ectopic expression of miR-181b decreases the CD133+ population, inhibits CSC-like properties, and enhances sensitivity to cisplatin treatment by targeting Notch2, thereby inactivating the Notch2/Hes1 signaling pathway [129].